Thames Valley Capital - Investor Profile and Portfolio

Developer for prognostic tests for assessing the risk of dementia. It is investigating SNP targets in the mTOR pathway to predict and diagnose mild cognitive impairment, which is considered to be an early indicator of dementia and Alzheimer's disease. The company has two products genoSCORE LAB and genoTOR that use blood and saliva for diagnostic approaches.

Sphere Medical, develops and commercializes monitoring products that provide clinical and economic benefits in the critical care environment. The latest of these is Proxima which is Sphere Medical’s patient dedicated analyser for use in the intensive care unit (ICU) and operating room (OR). The Proxima system has the potential to improve the care of the 12 million patients each year, who are cared for in this environment.

Surface Generation is a provider of carbon fibre processing technologies. The company uses its Productions to Functional Specifications Technology to optimise the carbon fibre processing. Its PtFS product range includes advanced heating, cooling and process control specifically designed for maximum performance in turnkey or retrofitted applications. Surface Generation offers customers’ access to R&D, test and commissioning facilities in Europe, Asia and North America. With the option of on or offsite running, users can process thermoplastics, thermosets, metals and glasses up to 850 degrees C using state-of-the-art PtFS systems in conventional or custom configurations. In addition, customers can access injection moulding (120 & 350 tonnes), compression moulding (100 tonnes), vacuum infusion and prepreg processing equipment for proof-of-concept, research and development purposes.